About MIEKA

MIEKA is a UK-based specialist supplier dedicated to supporting neonatal and infant care across the National Health Service through clinically proven medical technologies, dependable service, and long-term partnership with healthcare providers. Our purpose is simple and focused: to support the safe care of newborn and vulnerable infants by ensuring clinicians have access to reliable, compliant, and clinically proven medical equipment throughout the entire neonatal pathway. We are committed not only to supplying devices, but to working alongside NHS trusts, neonatal networks, and clinical engineering teams to deliver sustainable solutions for patients at the very start of life.

A clinically driven, NHS-aligned approach

Everything we do is shaped by the realities of neonatal care within UK hospitals. We work in close collaboration with:

NHS trusts and neonatal clinical teams

EBME and clinical engineering departments

Procurement and governance stakeholders

To ensure the technologies we provide are:

Safe, effective, and fully compliant with UK regulatory expectations

Practical within real clinical workflows and care environments

Supported throughout their full operational lifecycle

Our approach ensures our contribution extends beyond supply into measurable clinical reliability and service continuity.

Our Partnership Model

Built on manufacturing excellence, quality assurance, and clinical relevance.

Manufacturing Heritage

An established medical device manufacturer with decades of experience in design, engineering, and production. OKUMAN provides a robust manufacturing backbone for our UK activities.

UK Expertise

Combining global manufacturing capability with local UK expertise and support. We ensure transparency, traceability, and long-term reliability for our clinical partners.

Global Partner

Our international partner enabling a global footprint. This collaboration allows for continuous learning and alignment with international best practices in neonatal care.

A trusted partner to the NHS neonatal community

MIEKA is proud to be supported by UCL Innovation and Enterprise, the commercialisation and partnerships division of University College London.
This relationship reflects an ongoing commitment to clinical collaboration, evidence-based innovation, and responsible translation of technology into real healthcare environments.

Through engagement with one of the United Kingdom’s leading academic and clinical research ecosystems, MIEKA strengthens its ability to:

Align product development with current clinical research and neonatal care priorities
Contribute to evidence-driven evaluation and responsible adoption of medical technologies
Support innovation pathways that benefit NHS patients, clinicians, and healthcare systems

This connection reinforces our commitment to advancing safe, research-informed, and clinically meaningful innovation within the NHS.

Quality First

Quality and Regulatory Commitment

Quality and patient safety sit at the core of everything we do. MIEKA operates under internationally recognised quality management systems, including ISO 9001 and ISO 13485.

ISO 13485

Medical devices quality management systems.

ISO 9001

International standard for quality management.

"Our manufacturing partners also operate in accordance with internationally recognised quality management standards, and our processes are designed to support compliance with UK and international regulatory requirements. This commitment ensures that healthcare professionals can rely on equipment that meets rigorous performance, safety, and durability expectations in neonatal environments."

Our Commitment to the UK Neonatal Community

MIEKA is committed to being more than a supplier. We aim to be a long-term partner to the UK neonatal community by supporting clinical teams, engaging with NHS frameworks, and contributing to sustainable, patient-centred care.

Supporting those who care for the most vulnerable patients at the very start of life.